Bamifylline was found to be a poor inhibitor of 3′,5′-cyclic GMP phosphodiesterase (PDE V) as other methylxanthines such as teophylline and caffeine. The IC50 was respectively 3.24, 2.91, 1.69 mM. Inhibition decreased at higher cGMP concentrations. Lineweaver-Burk plots were linear or nearly linear. Differences in the actions of these inhibitors presumably reflect differences in the molecular requirements for effective interaction at the catalytic site on phosphodiesterase.
SaviniF.BerardiS.TatoneD.SpotoG.1995. Phosphodiesterase in human colon carcinoma cell line Caco-2 in culture. Life Sci.56:421
3.
ThompsonW.J.1991. Cyclic nucleotide phosphodiesterases: Pharmacology, biochemistry and function. Pharmacol. Ther.51:13
4.
SonnenburgW.K.MullaneyP.J.BeavoJ.A.1991. Molecular cloning of a cyclic GMP-stimulated cyclic nucleotide phosphodiesterase cDNA. Identification and distribution of isozyme variants. J. Biol. Chem.266:17655
5.
TanakaT.HockmanS.MoosM.J.TairaM.MeacciE.MurashimaS.ManganielloV.C.1991. Comparison of putative cGMP-binding regions in bovine brain and cardiac cGMP-stimulated phosphodiesterases. Second Messengers Phosphoproteins.13:87
6.
WhalinM.E.ScammellJ.G.StradaS.J.ThompsonW.J.1991. Phosphodiesterase II, the cGMP-activatable cyclic nucleotide phosphodiesterase, regulates cyclic AMP metabolism in PC12 cells. Mol. Pharmacol.39:711
7.
RepaskeD.R.CorbinJ.G.ContiM.GoyM.F.1993. A cyclic GMP-stimulated cyclic nucleotide phosphodiesterase gene is highly expressed in the limbic system of the rat brain. Neuroscience56:673
8.
MeacciE.TairaM.MoosM.J.SmithC.J.MovsesianM.A.DegermanE.BelfrageP.ManganielloV.1992. Molecular cloning and expression of human myocardial cGMP-inhibited cAMP phosphodiesterase. Proc.Natl.Acad.Sci.USA89:3721
9.
GeremiaR.RossiP.MociniD.PezzottiR.ContiM.1984. Characterization of a calmodulin-dependent high affinity cyclic AMP and cyclic GMP phosphodiesterase from male mouse germ-cells. Biochem. J.217:693
10.
ContiM.NemozG.SetteC.ViciniE.1995. Recent progress in understanding the hormonal regulation of phosphodiesterases. Endocrine Reviews16:370
11.
TairaM.HockmanS.C.CalvoJ.C.BelfrageP.ManganielloV.1993. Molecular cloning of the rat adipocyte hormone-sensitive cyclic GMP-inhibited cyclic nucleotide phosphodiesterase. J. Biol. Chem.268:18573
12.
MukaiJ.AsaiT.NakaM.TanakaT.1994. Separation and characterization of a novel isoenzyme of cyclic cucleotide phosphodiesterase from rat cerebrum. Br. J. Pharmacol.111:389
13.
JinS.L.SwinnenJ.V.ContiM.1992. Characterization of the structure of a low Km, rolipramsensitive cAMP phosphodiesterase. Mapping of the catalytic domain. J. Biol. Chem.267:18929
14.
FrancisS.H.ColbranJ.L.McAllister-LucasL.M.CorbinJ.D.1994. Zinc interactions and conserved motivs of the cGMP-binding cGMP-specific phosphodiesterase suggest that it is a zinc hydrolase. J. Biol. Chem.269:22477.
15.
SharmaR.K.1991. Phosphorilation and characterization of bovine heart calmodulin-dependent phosphodiesterase. Biochemistry30:5963
16.
BertiF.MagniF.1990. Pharmacological activity of Bamifylline of lung anaphylaxis: In vitro studies. Pharmacol. Res.22, 143
17.
SchraderJ.KrollK.HenrichM.PiperH.M.1987. Coronary and myocardial adenosine receptors. Biomed. Biochem. Acta46:S421
18.
CerùM.P.CarlucciG.1989. Detection of clofibric acid by high- performance liquid chromatography in serum of newborns from clofibrate treatd rats. Int. J. Immunopathol. Pharmacol.2:9
19.
PalumboG.CarlucciG.SpontaA.M.FaniniD.1990. Comparison of high- performance liquid chromatography and microbiological assay for the determination of ofloxacin in serum and urine in humans. Int. J. Immunopathol. Pharmacol.3:159
20.
SpotoG.WhiteheadE.FerraroA.Di TerlizziP.M.TuranoC.RivaF.1991. A reverse-phase HPLC method for cAMP phosphodiesterase activity. Anal. Biochem.196:207
21.
SpotoG.BerardiS.AjerbaG.De LaurentisV.1995. A reverse-phase HPLC method for cyclic nucleotide phosphodiesterases activity and classification. Adv. Exp. Med. and Biol.370:815
22.
BertiF.MagniF.RossoniS.SchiantarelliS.BongraniS.PasargiklianR. R.1988. New pharmacological data on the bronchospasmolytic activity of bamifylline. Arzneim Forsch/Drug Res38:40
23.
BeavoJ.A.ReifsnyderD.H.1990. Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors. Trends Pharmacol. Sci.11:150